We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ENV105 can potentially address resistance in a wide range of cancers as they become resistant to standard treatments. Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.29 | 20.2797202797 | 1.43 | 1.77 | 1.33 | 95759 | 1.55807183 | CS |
4 | -0.34 | -16.5048543689 | 2.06 | 2.07 | 1.33 | 128710 | 1.56696012 | CS |
12 | -0.63 | -26.8085106383 | 2.35 | 2.75 | 1.22 | 344529 | 2.02248848 | CS |
26 | -2.28 | -57 | 4 | 4 | 1.22 | 334402 | 2.03828743 | CS |
52 | -2.28 | -57 | 4 | 4 | 1.22 | 334402 | 2.03828743 | CS |
156 | -2.28 | -57 | 4 | 4 | 1.22 | 334402 | 2.03828743 | CS |
260 | -2.28 | -57 | 4 | 4 | 1.22 | 334402 | 2.03828743 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions